Home > Healthcare > Drug Device Combination > Drug Filled Devices > U.S. Hormone Replacement Therapy Market

U.S. Hormone Replacement Therapy Market Size

Report ID: GMI7407
Published Date: Nov 2023
Report Format: PDF

Download Free Sample

U.S. Hormone Replacement Therapy Market Size

The U.S. Hormone Replacement Therapy Market size in 2022 was evaluated to be USD 6.9 billion and is anticipated to be valued at USD 13.4 billion by 2032. The aging U.S. population, with a significant number of women reaching menopausal stages, is a primary driver of the HRT market. As people age, there is an increased prevalence of hormonal imbalances and associated symptoms, resulting in a heightened demand for hormone replacement therapies.

To get key market trends

Download Free Sample

Furthermore, rising cases of thyroid disorders and other endocrine disorders is aiding the market progress. For instance, as per a study published by NIH, in 2022, prevalence of hypothyroidism (HT) was approximately 4.6% in the U.S. population. Additionally, with a surge in the number of specialized clinics and healthcare providers offering HRT coupled with a paradigm shift towards personalized and preventative healthcare in the market is poised to witness high growth.

U.S. Hormone Replacement Therapy Market Report Attributes
Report Attribute	Details
Base Year:	2022
U.S. Hormone Replacement Therapy Market Size in 2022:	USD 6.9 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	6.5 %
2032 Value Projection:	USD 13.4 Billion
Historical Data for:	2018 to 2022
No. of Pages:	91
Tables, Charts & Figures:	60
Segments covered:	Product, Route of Administration, Disease Type, and Distribution Channel
Growth Drivers:	Increasing geriatric population Rising awareness of post-menopausal issues Increasing development of novel drug delivery systems for hormone imbalance issues Rising prevalence of hormonal disorders
Pitfalls & Challenges:	High cost associated with hormone replacement therapy Adverse effects of hormone replacement therapy

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. hormone replacement therapy industry size was USD 6.9 billion in 2022 and is anticipated to be valued at USD 13.4 billion from 2023-2032 due to the aging population and the significant number of women reaching menopausal stages.

The oral route of administration recorded 43.5% share of the market in 2022 driven by non-invasive nature, precise and consistent drug dosing, affordability, and the strong preference of patients.

The hospital pharmacies distribution channel segment held 57.2% of the U.S. hormone replacement therapy market share in 2022 due to the presence of the highest quality of care.

Some of the major hormone replacement therapy firms in the U.S. include Eli Lilly and Company, Bayer AG, Pfizer Inc., Viatris, Inc., Noven Pharmaceuticals, Inc., Merck KGaA, Novo Nordisk A/S, and F. Hoffmann-La Roche Ltd.